Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects.
Related Research units
Abstract
Bibliographical data
Original language | English |
---|---|
Article number | 10 |
ISSN | 0171-5216 |
Publication status | Published - 2006 |
pubmed | 16761121 |
---|